Provides updates of recent ISPOR activities and events.
2018
ISPOR eBulletin (February 2018)
ISPOR eBulletin (January 2018)
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
ISPOR eBulletin Index

APRIL 2012

Welcome to the April 2012 edition of the ISPOR eBulletin. The ISPOR eBulletin provides updates of recent ISPOR events and accomplishments. For more information, see: www.ispor.org.

ANNOUNCEMENTS

2012 ISPOR Board of Directors Election

DEADLINE TO VOTE: MAY 1, 2012

This is a reminder to vote for the 2012-2013 ISPOR Board of Directors candidates. In this election, you have the opportunity to vote for the President-Elect (term of office 2012-2013 as President-Elect and 2013-2014 as President) and four Directors (2012-2014). Please vote online via the ISPOR website.

ISPOR Board of Directors Election 2012 »

 

Value in Health Regional Issues Editorial Advisory Board

The new ViHRI EAB has been selected.  To view the new EAB members, see: Value in Health Regional Issues Editorial Advisory Board »

 

ISPOR CONNECTIONS New Editor-in-Chief

The ISPOR Board of Directors is proud to announce Rachael Fleurence, PhD, as the new Editor-in-Chief of ISPOR CONNECTIONS. Dr. Fleurence’s term will begin her term July 1, 2012.

 

ISPOR STUDENT TRAVEL GRANTS AND MEETING TRAVEL SCHOLARSHIP AWARDS

ISPOR Student Travel Grants and Meeting Travel Scholarship Awards are now available for all 2012 ISPOR meetings (a maximum of 10 awards are available for each meeting). Deadlines are:

  • 17th Annual International Meeting, Washington, DC, USA
    (June 2-6, 2012): Friday, April 6, 2012
  • 4th Asia-Pacific Conference, Taipei, Taiwan
    (2-4 September 2012): July 13, 2012
  • 15th Annual European Congress, Berlin, Germany
    (3-7 November 2012): September 7, 2012

For applicant criteria and application, see:

MEETINGS

ISPOR 17th Annual International Meeting, Washington, DC, USA, June 2-6, 2012

Improving Health Care Efficiency

MEETING FEATURES OVER 1,300 PRESENTATIONS

Register before April 17th for discounted rates

ISPOR 17th Annual International Meeting Program »

 

Plenary Sessions:
COMPARING THE EFFECTIVENESS OF NEW DRUGS: SHOULD THE FDA BE ASKING 'DOES IT WORK' OR 'DOES IT WORK BETTER'?
Moderator/Speaker: Sean Tunis, MD, MSc, Founder & Director, Center for Medical Technology Policy
Speakers: Mark B. McClellan, MD, PhD, Director, Engelberg Center for Health Care Reform, Senior Fellow, Economic Studies & Leonard D. Schaeffer Chair in Health Policy Studies, Brookings Institution; Vicki L. Seyfert-Margolis, PhD, Senior Advisor, Science Innovation and Policy, Office of the Chief Scientist, Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring
HEALTH REFORM IN THE US: WILL STATE HEALTH INSURANCE EXCHANGES IMPROVE THE EFFICIENCY AND AFFORDABILITY OF HEALTH CARE IN THE US?
Moderator/Speaker: Susan Dentzer, MA, Editor-in-Chief, Health Affairs
Speakers: John E. McDonough, DrPH, MPA, Professor of the Practice of Public Health, Director of the Center for Public Health Leadership, Department of Health Policy and Management, Harvard School of Public Health; Joshua M. Sharfstein, MD, Secretary, Maryland Department of Health and Mental Hygiene

PERFORMANCE-BASED RISK-SHARING ARRANGEMENTS: GOOD RESEARCH PRACTICES FOR DESIGN, IMPLEMENTATION AND EVALUATION
Speakers: Lou Garrison, PhD, Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington School of Pharmacy; Adrian Towse, MA, MPhil, Director, Office of Health Economics

30 Short Courses

15 Issue Panels

31 Workshops

60 Podium Presentations

Forums: Session I and Session II

Over 1250 Poster Presentations NEW 5 poster sessions!

8 Educational Symposia

 

ISPOR 5th Asia-Pacific Conference, Taipei, Taiwan,
2-4 September, 2012

OVER 500 ABSTRACTS SUBMITTED (25% INCREASE)

Register

For program, support, exhibit, advertising and symposium opportunities, see: ISPOR 5th Asia-Pacific Conference »

 

Plenary Sessions:

HEALTH TECHNOLOGY ASSESSMENT IN THE SIGNIFICANTLY EVOLVING HEALTH CARE SYSTEMS IN ASIA 
INVOLVING PATIENTS & HEALTH CARE PROVIDERS IN HEALTH CARE DECISIONS: LEARNING FROM EACH OTHER
CHALLENGES OF ADOPTING NEW INNOVATIVE TECHNOLOGIES IN HEALTH CARE COVERAGE DECISION-MAKING IN ASIA

ISPOR 15th Annual European Congress, Berlin, Germany,

 3-7 November, 2012

ABSTRACT SUBMISSION OPEN: DEADLINE 26 JUNE

NEW Congress format for 2012:

ISPOR Short Courses Saturday & Sunday

Congress Program Monday, Tuesday & Wednesday

For sponsorship, exhibit, advertising and symposium opportunities, see: ISPOR 15th Annual European Congress »

PUBLICATIONS

Value in Health Volume 15, Issue 2 On-Line

Value in Health Volume 15, Issue 2 is now available on-line.

In this issue:

ISPOR Task Force Report– Prospective Observational Studies to Assess Comparative Effectiveness: ISPOR Good Research Practices Task Force Report
Preference-based Assessment Improving The Measurement Of QALYs In Dementia: Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis
Health Policy Analysis Antihypertensive Drugs: A Perspective On Pharmaceuticals Price Erosion And Its Impact On Cost-Effectiveness
Policy Perspectives– Conducting Comparative Effectiveness Research: The Views Of A Practicing Epidemiologist From The Other Washington

Additional topics in this issue of Value in Health are Economic Evaluation, Patient Reported Outcomes, and Comparative Effectiveness Research/Health Technology Assessment.

Value in Health »

ISPOR SPECIAL INTEREST GROUPS/TASK FORCES

AMCP/ISPOR/NPC Tool Kit for Decision Makers

ISPOR will convene a focus group with AMCP members involved in formulary decision making during the AMCP 24th Annual Meeting & Expo (April 18-20, 2012), to solicit feedback on a set of ‘Assessment Tools’ to evaluate retrospective studies, prospective studies, network meta-analysis studies, and modeling studies. These tools are part of the AMCP/ISPOR/NPC Comparative Effective Research Collaborative Initiative to develop a user-friendly toolkit to help decision makers navigate through the various types of studies (used to generate outcomes research information) to enhance the formulary decision-making process. For more information, see: Comparative Effectiveness Research - Collaborative Initiative (CER-CI)
Advancing Appropriate Use of Comparative Evidence to Improve Patient Health Outcomes »

ISPOR GLOBAL OUTREACH

ISPOR Asia Consortium

ISPOR Asia Consortium is proud to present the first issue the of Asia Consortium newsletter, News Across Asia. The newsletter serves to inform and update ISPOR members on Asia Consortium initiatives as well as for sharing news of PE/OR in Asia. To view the newsletter, see: News Across Asia

  

ISPOR Iran Regional Chapter

ISPOR welcomes the newly formed ISPOR Iran Regional Chapter. This new chapter will be actively involved with further development of pharmacoeconomics and outcomes research in Iran and in Asia. For more details, see: ISPOR Iran Regional Chapter » 

 

ISPOR India-Karnataka Regional Chapter

The ISPOR India-Karnataka Chapter will hold a one-day workshop, “Conducting Population-Based Clinical Outcomes Research,” on 19 April 2012, at Manipal College of Pharmaceutical Sciences, Manipal, India. For more details, see: ISPOR India-Karnataka Regional Chapter» 

 

ISPOR Japan Regional Chapter

The ISPOR Japan Chapter held its 8th Annual Meeting on               Sunday, 25 March 2012, entitled, “Roles of Medical Economics Assessment in Japanese Health Care Policy.”  For more details, see: ISPOR Japan Regional Chapter » 

 

ISPOR Malaysia Regional Chapter

The ISPOR Malaysia Chapter held the 1st Pharmacoeconomics and Outcome Research Conference, from 30 March to 1 April 2012, in Kuala Lumpur, Malaysia. For more details, see: ISPOR Malaysia Regional Chapter »

 

ISPOR Saudi Arabia Regional Chapter

The ISPOR Saudi Arabia Chapter will be the co-organizer of the 2nd Saudi International Pharmacoeconomics Conference, “Better Analysis for Better Healthcare Decisions in KSA,” 28-30 April 2012. For program details, see: ISPOR Saudi Arabia Regional Chapter »

 

ISPOR Serbia Regional Chapter

The ISPOR Serbia Chapter has translated the ISPOR book, Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms into Serbian. The Chapter also has new leadership. For information on the newly elected President and Board of Directors members, as well as information on the translated book, see: ISPOR Serbia Regional Chapter »

OTHER ANNOUNCEMENTS

AMCP Announcement: Revision of AMCP Format for Formulary Submission

The Academy of Managed Care Pharmacy (AMCP) has commissioned the Format Executive Committee to assemble a team of experts to develop and publish three addenda/appendices to AMCP’s Format for Formulary Submissions Version 3.0. To view the agenda, see: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=19161.  For further information, contact Marissa Schlaifer, Director of Pharmacy Affairs, at: mschlaifer@amcp.org.

TIP OF THE MONTH

ISPOR Research Tools

To view ISPOR's Health Science Initiatives, Patient Reported Outcomes, and QOL Activities & Accomplishments from 1999 – 2006, go to the "ISPOR Research Tools" Tab on the purple tool bar and select any of our four areas.

ADVERTISEMENTS

ARCHeS_Innovator-transp-png.png

The transparent HEOR simulation model

 

Continual validation and calibration are an integral part of the model-building process, essential for:

 

  • Developing confidence in the results
  • Identifying ways to improve the mode

 

The complete calibration and validation reports of Simulator 2.3, the part of the Archimedes Model behind ARCHeS Innovator, are now available for download at:

archimedesmodel.com/arches-transparency

_____________________________________________________

 

OXFORD OUTCOMES: COURSES AND SYMPOSIA

 

Evolutions in Network Meta-Analysis Course

May 29, 2012, Delta Toronto Airport West Hotel

Toronto, ON, Canada

 

Are you interested in?

 

  • Increasing your knowledge on indirect and mixed treatment comparison meta-analysis
  • How indirect and mixed treatment comparison meta-analysis is used as a tool for Health Technology Assessment (Canadian focus)
  • How indirect and mixed treatment comparison calculations are made

 

Join Neil Hawkins, Vice President, Health Economics at Oxford Outcomes, and George Wells, Professor in the Department of Epidemiology and Community Medicine at the University of Ottawa for a programme of sessions designed to build knowledge and invite debate.

For more information, click here.

 

European Health Economics and Outcomes Research Symposium

19, June 2012, Institute of Directors

London, United Kingdom

 

Join opinion leaders for a programme of cutting edge methodological and regulatory debate.

Key note speakers confirmed:

  • Paul Dolan, Professor of Behavioural Science at London School of Economics
  • Peter Gray former CEO of ICON Plc. Current Vice Chairman of ICON Plc.

 

For more information and to register, please email: louise.boxall@oxfordoutcomes.com

_________________________________________________

 

 

NEW: Fall Session of the established 3-week course

“Health Economics, Technology Assessment

 and Market Access”

By the European School of Health Economics

October 8-12,   November 12-16, November 26-29, 2012

 

For the first time, a fall session of the 3-week course “Health Economics of Pharmaceuticals and other Medical Interventions,” will be organized. This course is supported by faculty from academia, authorities and industry and has been running over 20 times and in excess of 500 students have participated. The fall session is modular where each week can also be taken alone. The course addresses issues for both pharmaceuticals and medical devices.

 

Week 1

Economics of health care, health policy, health technology assessment, market access in key markets, pricing in a global environment, overview of economic evaluation.

Target audience: professionals involved in market access, pricing, regulatory issues, clinical research, project management and outcomes research.

Week 2

Health economics methodology: Descriptive and evaluative economic analyses.

Target audience: professionals working in outcomes research in industry or academia, reimbursement organizations or health technology assessment groups. 

Week 3

Modeling using TreeAge and Excel.

Target audience:  professionals working in outcomes research in industry or academia, reimbursement organizations or health technology assessment groups

      

For information, see: www.he-europe.com, or email Gisela Kobelt at: gisela.kobelt@he-europe.com.

 

 

IMPORTANT DATES TO REMEMBER

 

April 17, 2012

ISPOR 17th Annual International Meeting Early Registration Deadline

More »

 

May 1, 2012

ISPOR Board of Directors Voting Deadline

 

24 July 2012

ISPOR 5th Asia-Pacific Conference

 Early Registration Deadline

More »

 

26 June 2012

ISPOR 15th Annual European Congress Abstract Submission Deadline